Rolf A. Klaasen
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
The Effect of Certolizumab Pegol Dose and Dose Changes on Plasma Trough Levels: Data From a Randomized Phase III Trial.
Journal: Therapeutic drug monitoring
Published: April 30, 2025
Serological screening for coeliac disease in an adult general population: the HUNT study.
Journal: Gut
Published: September 14, 2024
A simple automated assay format for measuring multiple immune checkpoint inhibitors.
Journal: Journal of pharmaceutical and biomedical analysis
Published: August 27, 2024
The Prevalence and Rate of Undiagnosed Celiac Disease in an Adult General Population, the Trøndelag Health Study, Norway.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: February 03, 2024
Effects of prednisolone tapering on effectiveness of infliximab in patients with ulcerative colitis: data from a retrospective cohort.
Journal: BMJ open gastroenterology
Published: January 06, 2024
Therapeutic drug monitoring of vedolizumab therapy in inflammatory bowel disease.
Journal: Journal of gastroenterology and hepatology
Published: November 01, 2023
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials.
Journal: The Lancet. Rheumatology
Published: September 14, 2023
HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases.
Journal: Journal of internal medicine
Published: February 27, 2023
Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial.
Journal: Journal of internal medicine
Published: April 12, 2022
Last Updated: 09/26/2026